J. Taubert

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

JNJ

Current role

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Johnson & Johnson (JNJ)	EVP, WWC Innovative Medicine	$1,220,308	$0	$6,160,665	$2,430,013	$2,002,750	$89,963	$14,030,063
2024	Johnson & Johnson (JNJ)	EVP, WWC Innovative Medicine	$1,192,308	$0	$4,670,057	$2,129,987	$1,909,125	$62,568	$11,190,045
2023	Johnson & Johnson (JNJ)	EVP, WWC Innovative Medicine	$1,130,000	$0	$4,246,820	$1,799,992	$1,896,250	$78,332	$10,995,394
2022	Johnson & Johnson (JNJ)	EVP, WWC Innovative Medicine	$1,008,462	$0	$4,764,921	$1,859,958	$1,094,875	$53,316	$8,781,532
2021	Johnson & Johnson (JNJ)	EVP, WWC Innovative Medicine	$938,077	$0	$4,947,245	$1,713,005	$1,510,314	$49,707	$10,225,759
2020	Johnson & Johnson (JNJ)	EVP, Worldwide Chair Pharmaceuticals	$884,615	—	$4,468,928	$1,499,997	$990,058	$46,871	$9,532,469

No earnings-call appearances or filed executive changes recorded yet.